Inventor profile of:

Eric Olson

City:

Dallas, Texas

Country:

United States

Published Applications:

27

Last publication date:

2025-06-05

Top Assignees for applications by Eric Olson

The entities that hold a legal rights for patent applications filed by inventor Olson Eric:

Recent patent applications by Olson Eric

Eric Olson from Dallas, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-06-05
US20250179450A1
Chemistry; metallurgy

CRISPR/SpCas9 VARIANT AND METHODS FOR ENHANCED CORRECTION OF DUCHENNE MUSCULAR DYSTROPHY MUTATIONS

#2 | 2023-02-16
US20230053219A1
Human necessities

COMPOSITIONS AND METHODS RELATING TO MYOMAKER-INDUCED MUSCLE CELL FUSION

#3 | 2021-08-26
US20210261962A1
Chemistry; metallurgy

CORRECTION OF DYSTROPHIN EXON 43, EXON 45, OR EXON 52 DELETIONS IN DUCHENNE MUSCULAR DYSTROPHY

#4 | 2020-09-03
US20200275641A1
Human necessities

GENERATION AND CORRECTION OF A HUMANIZED MOUSE MODEL WITH A DELETION OF DYSTROPHIN EXON 44

#5 | 2019-11-28
US20190358294A1
Human necessities

Compositions and methods relating to myomaker-induced muscle cell fusion

#6 | 2018-09-27
US20180271069A1
Human necessities

Generation and correction of a humanized mouse model with a deletion of dystrophin exon 44

#7 | 2016-05-19
US20160136240A1
Human necessities

Compositions and methods relating to myomaker-induced muscle cell fusion

#8 | 2015-03-26
US20150087693A1
Chemistry; metallurgy

Micro-RNAs involved in macular degeneration

#9 | 2014-10-09
US20140303236A1
Chemistry; metallurgy

Control of whole body energy homeostasis by microRNA regulation

#10 | 2013-01-31
US20130030035A1
Human necessities

Identification of micro-RNAs involved in neuromuscular synapse maintenance and regeneration

#11 | 2012-02-09
US20120035243A1
Chemistry; metallurgy

Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders

#12 | 2011-12-01
US20110293674A1
Chemistry; metallurgy

MICRO-RNAs THAT MODULATE SMOOTH MUSCLE PROLIFERATION AND DIFFERENTIATION

#13 | 2011-07-14
US20110171196A1
Chemistry; metallurgy

METHODS OF TREATMENT AND USES FOR CAMKII AND ITS INTERACTION WITH HDACS AND CALPAIN

#14 | 2010-12-16
US20100317713A1
Human necessities

Micro-RNAS of the MIR-15 family modulate cardiomyocyte survival and cardiac repair

#15 | 2010-11-11
US20100285073A1
Chemistry; metallurgy

Micro-RNA family that modulates fibrosis and uses thereof

#16 | 2010-10-21
US20100269183A1
Chemistry; metallurgy

Micro-RNAs that control myosin expression and myofiber identity

#17 | 2009-10-01
US20090246136A1
Human necessities

Identification of micro-RNAS involved in neuromuscular synapse maintenance and regeneration

#18 | 2009-09-10
US20090226375A1
Chemistry; metallurgy

Micro-RNAs that modulate smooth muscle proliferation and differentiation and uses thereof

#19 | 2009-07-16
US20090180957A1
Chemistry; metallurgy

Identification of a micro-RNA that activates expression of β-myosin heavy chain

#20 | 2009-03-19
US20090076103A1
Chemistry; metallurgy

Stem cell differentiating agents and uses therefor

#21 | 2007-07-12
US20070162984A1
Chemistry; metallurgy

Stars—A muscle-specific actin-binding protein

#22 | 2007-06-21
US20070142285A1
Chemistry; metallurgy

Methods of treatment and uses for CaMKII and its interaction with HDACs and calpain

#23 | 2007-01-09
US10077583
-

CHAMP—a novel cardiac helicase-like factor

#24 | 2006-07-04
US10644659
-

STARS—a muscle-specific actin-binding protein

#25 | 2005-12-01
US20050265999A1
Human necessities

Modulation of 5-HT2 receptors as a treatment for cardiovascular diseases

#26 | 2005-08-18
US20050182011A1
Human necessities

Inhibition of TRP channels as a treatment for cardiac hypertrophy and heart failure

#27 | 2005-05-26
US20050112128A1
Human necessities

Inhibition of protein kinase c-mu (PKD) as a treatment for cardiac hypertrophy and heart failure

InventorID:

68697 ⎘